Resistance among problem respiratory pathogens in pediatrics

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Beta-lactamase production in Haemophilus influenzae has risen to 35% over two decades.
• Moraxella catarrhalis isolates predominantly produce beta-lactamase, rendering them resistant to ampicillin and amoxicillin.
• Increasing penicillin resistance in Streptococcus pneumoniae, due to altered penicillin-binding proteins, poses a significant challenge.

Purpose of the Study:

• To assess current antimicrobial resistance patterns in key pediatric respiratory pathogens.
• To evaluate the effectiveness of various oral antibiotics against these resistant strains.
• To highlight the implications of emerging resistance for clinical treatment strategies.

Main Methods:

• Review of antimicrobial susceptibility data for clinical isolates of H. influenzae, M. catarrhalis, and S. pneumoniae.
• Analysis of resistance trends over the past two decades.
• Evaluation of activity of beta-lactam and non-beta-lactam oral antimicrobials.

Main Results:

• Amoxicillin/clavulanate, cefuroxime, and cefpodoxime show sustained activity against H. influenzae and M. catarrhalis.
• Resistance rates to tetracycline, trimethoprim/sulfamethoxazole, and macrolides remain low (1-5%) for H. influenzae.
• 15-25% of S. pneumoniae isolates exhibit penicillin resistance; third-generation cephalosporins retain activity but emerging resistance is a concern.

Conclusions:

• While resistance is increasing in S. pneumoniae, alternative oral agents remain viable for H. influenzae and M. catarrhalis infections.
• Continuous monitoring of antimicrobial resistance patterns is crucial for effective pediatric infectious disease management.
• Emerging resistance in S. pneumoniae necessitates careful selection of antibiotics and consideration of novel therapeutic strategies.